JinkoSolar Holding Co., Ltd. (JKS)
After hours: 07:58PM EDT
| Previous close | 50.45 |
| Open | 51.65 |
| Bid | 51.30 x 800 |
| Ask | 51.85 x 900 |
| Day's range | 50.40 - 53.07 |
| 52-week range | 28.39 - 90.20 |
| Volume | 1,666,258 |
| Avg. volume | 1,803,234 |
| Market cap | 2.468B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 65.20 |
| EPS (TTM) | 0.79 |
| Earnings date | 06 Dec 2021 - 10 Dec 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 41.19 |
- Zacks
Enphase (ENPH) to Install IQ 7+ in New South Wales Village
Enphase Energy's (ENPH) IQ7+ microinverters have been selected for a 1.2 MW private power grid in New South Wales. The move strengthens its position in Australia.
- Business Wire
Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology Officer
AUSTIN, Texas, September 28, 2021--Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the Company has strengthened its leadership team with the appointments of Mark S. Berger, M.D. to the newly-created position of Chief Medical Officer and Hemant Kumar, Ph.D., CPM, EMBA to the newly-created position of Chief Manufacturing and Technology Officer.
- Oilprice.com
5 Energy Stocks At Biggest Risk From The Evergrande Implosion
Solar stocks have emerged as some of the worst-hit among the many sectors feeling the heat from growing contagion fears as the Evergrande crisis continues to unfold
